carbapenems has been researched along with oxazoles in 2 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (oxazoles) | Trials (oxazoles) | Recent Studies (post-2010) (oxazoles) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 9,281 | 366 | 2,561 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Long, TE | 1 |
| Caminero, JA; Scardigli, A | 1 |
1 review(s) available for carbapenems and oxazoles
| Article | Year |
|---|---|
Recent progress toward the clinical development of new anti-MRSA antibiotics.
Topics: 4-Quinolones; Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Coumarins; Humans; Methicillin Resistance; Oxazoles; Peptides; Staphylococcus aureus | 2003 |
1 other study(ies) available for carbapenems and oxazoles
| Article | Year |
|---|---|
Classification of antituberculosis drugs: a new proposal based on the most recent evidence.
Topics: Antitubercular Agents; Carbapenems; Clavulanic Acid; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Infectious Disease Medicine; Linezolid; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |